Literature DB >> 11463990

Mesenchymal differentiation and organ distribution of established human stromal cell lines in NOD/SCID mice.

K Thalmeier1, P Meissner, S Moosmann, S Sagebiel, I Wiest, R Huss.   

Abstract

Two human stromal cell lines were established previously from bone marrow-derived primary long-term cultures by immortalization using the SV40 large T antigen and cellular cloning. After irradiation, the fibroblast-like cell lines L87/4 and L88/5 support hematopoietic differentiation of allogeneic cord blood cells in vitro. The stromal cells do not express CD34 and CD50, but some adhesion molecules and integrins, such as CD44, CD54 and CD58. Their expression profiles on RNA and protein levels are suggestive of their osteogenic potency. The quality and quantity of osteocalcin and osteopontin protein expression depended on the culture conditions. Expression of the osteogenic markers increased over time in culture, especially in cells growing in clusters. The stromal cells also expressed collagens I and V, but did not show any expression of collagens II and III. The potentially osteoblastic stromal cells were transplanted into NOD/ SCID recipient mice by intravenous injection and were found in various mesenchymal organs up to 10 weeks after transplantation. Osteocalcin-positive human stromal cells could be detected in the bone marrow, thymus, liver, brain and gut of the recipient animals. In summary, there is evidence that human bone-marrow-derived stromal cells have to be considered mesenchymal progenitors, persistently expressing osteogenic markers in vitro and in vivo. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463990     DOI: 10.1159/000046559

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  6 in total

Review 1.  [Cell-based strategies for salivary gland regeneration].

Authors:  N Rotter; C Wirz; J Oder; B Wollenberg; R Huss; S Brandau; S Lang; M Bücheler
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

Review 2.  [Salivary gland stem cells : Can they restore radiation-induced salivary gland dysfunction?].

Authors:  N Rotter; S Schwarz; M Jakob; S Brandau; B Wollenberg; S Lang
Journal:  HNO       Date:  2010-06       Impact factor: 1.284

Review 3.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Authors:  Michele Bouloy; Ramon Flick
Journal:  Antiviral Res       Date:  2009-08-12       Impact factor: 5.970

4.  Fate of bone marrow-derived stromal cells after intraperitoneal infusion or implantation into femoral bone defects in the host animal.

Authors:  Timothy Wilson; Christoffer Stark; Johanna Holmbom; Ari Rosling; Asko Kuusilehto; Teemu Tirri; Risto Penttinen; Erika Ekholm
Journal:  J Tissue Eng       Date:  2010-08-01       Impact factor: 7.813

5.  Medium Perfusion Flow Improves Osteogenic Commitment of Human Stromal Cells.

Authors:  Alice Pasini; Joseph Lovecchio; Giulia Ferretti; Emanuele Giordano
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

6.  Bone marrow-derived mesenchymal stem cells migrate to healthy and damaged salivary glands following stem cell infusion.

Authors:  Silke Schwarz; Ralf Huss; Michaela Schulz-Siegmund; Breda Vogel; Sven Brandau; Stephan Lang; Nicole Rotter
Journal:  Int J Oral Sci       Date:  2014-05-09       Impact factor: 6.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.